Works by Fengmei Xu

Results: 19

The impacts of gray products and counterfeits in the luxury industry.

Published in:

International Journal of Production Research, 2024, v. 62, n. 14, p. 5252, doi. 10.1080/00207543.2023.2289644

By:

Xu, Fengmei;
Shan, Feifei;
Yang, Feng;
Chen, Ting

Publication type:

Article

Application of adjustable abduction neutral rehabilitation bracket for patients with femoral head department.

Published in:

Chinese Nursing Research, 2016, v. 30, n. 1B, p. 184, doi. 10.3969/j.issn.1009-6493.2016.02.019

By:

Xu Fengmei;
Kong Fanjun;
Zhang Lian

Publication type:

Article

PKCα-GSK3β-NF-κB signaling pathway and the possible involvement of TRIM21 in TRAIL-induced apoptosis.

Published in:

Biochemistry & Cell Biology, 2016, v. 94, n. 3, p. 256, doi. 10.1139/bcb-2016-0009

By:

Gao, Xuejuan;
Xu, Fengmei;
Zhang, Huan-Tian;
Chen, Miaojuan;
Huang, Wensi;
Zhang, Qihao;
Zeng, Qingzhong;
Liu, Langxia

Publication type:

Article

Prevalence of thyroid dysfunction in older Chinese patients with type 2 diabetes—A multicenter cross-sectional observational study across China.

Published in:

PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216151

By:

Zhu, Yu;
Xu, Fengmei;
Shen, Jie;
Liu, Youshuo;
Bi, Changhua;
Liu, Jing;
Li, Yufeng;
Wang, Xueqin;
Gao, Zhengnan;
Liang, Linlang;
Chen, Yanyan;
Sun, Weiping;
Guan, Qingbo;
Zhang, Junqing;
Luo, Zuojie;
Guo, Lixin;
Cai, Xiaopin;
Li, Ling;
Xiu, Lingling;
Yan, Li

Publication type:

Article

Product Introduction with Parallel Importation.

Published in:

Asia-Pacific Journal of Operational Research, 2025, v. 42, n. 2, p. 1, doi. 10.1142/S0217595924500131

By:

Xu, Fengmei;
Yang, Feng;
Shan, Feifei;
Chen, Ting

Publication type:

Article

The interaction between manufacturer encroachment and gray market.

Published in:

RAIRO: Operations Research (2804-7303), 2024, v. 58, n. 4, p. 2927, doi. 10.1051/ro/2024092

By:

Xu, Fengmei;
Yang, Feng;
Shan, Feifei;
Chen, Ting

Publication type:

Article

Association of visceral fat area or BMI with arterial stiffness in ideal cardiovascular health metrics among T2DM patients.

Published in:

Journal of Diabetes, 2024, v. 16, n. 1, p. 1, doi. 10.1111/1753-0407.13463

By:

Zhao, Ling;
Zhou, Xiangming;
Chen, Yufei;
Dong, Qijuan;
Zheng, Qidong;
Wang, Yufan;
Li, Li;
Zhao, Dong;
Ji, Bangqun;
Xu, Fengmei;
Shi, Juan;
Peng, Ying;
Zhang, Yifei;
Dai, Yuancheng;
Ke, Tingyu;
Wang, Weiqing

Publication type:

Article

The effects of economic status on metabolic control in type 2 diabetes mellitus at 10 metabolic management centers in China.

Published in:

Journal of Diabetes, 2024, v. 16, n. 1, p. 1, doi. 10.1111/1753-0407.13466

By:

Gu, Liping;
Ma, Yuhang;
Zheng, Qidong;
Gu, Weiqiong;
Ke, Tingyu;
Li, Li;
Zhao, Dong;
Dai, Yuancheng;
Dong, Qijuan;
Ji, Bangqun;
Xu, Fengmei;
Shi, Juan;
Peng, Ying;
Zhang, Yifei;
Shen, Tingting;
Du, Rui;
Yang, Jiaying;
Kang, Mei;
Peng, Yongde;
Wang, Yufan

Publication type:

Article

Follow‐up frequency and clinical outcomes in patients with type 2 diabetes: A prospective analysis based on multicenter real‐world data.

Published in:

Journal of Diabetes, 2022, v. 14, n. 5, p. 306, doi. 10.1111/1753-0407.13271

By:

Zhao, Qiubo;
Li, Hongwei;
Ni, Qicheng;
Dai, Yuancheng;
Zheng, Qidong;
Wang, Yufan;
Ke, Tingyu;
Li, Li;
Zhao, Dong;
Dong, Qijuan;
Ji, Bangqun;
Shi, Juan;
Peng, Ying;
Zhang, Yifei;
Xu, Fengmei;
Wang, Weiqing

Publication type:

Article

Kidney disease parameters, metabolic goal achievement, and arterial stiffness risk in Chinese adult people with type 2 diabetes.

Published in:

Journal of Diabetes, 2022, v. 14, n. 5, p. 345, doi. 10.1111/1753-0407.13269

By:

Xu, Chen;
Li, Li;
Shi, Juan;
Ji, Bangqun;
Zheng, Qidong;
Wang, Yufan;
Ke, Tingyu;
Zhao, Dong;
Dai, Yuancheng;
Xu, Fengmei;
Peng, Ying;
Zhang, Yifei;
Dong, Qijuan;
Wang, Weiqing

Publication type:

Article

Effects of basal and premixed insulin on glycemic control in type 2 diabetes patients based on multicenter prospective real‐world data.

Published in:

Journal of Diabetes, 2022, v. 14, n. 2, p. 134, doi. 10.1111/1753-0407.13245

By:

Peng, Ying;
Xu, Peihong;
Shi, Juan;
Zhang, Yifei;
Wang, Shujie;
Zheng, Qidong;
Wang, Yufan;
Ke, Tingyu;
Li, Li;
Zhao, Dong;
Dai, Yuancheng;
Dong, Qijuan;
Ji, Bangqun;
Xu, Fengmei;
Gu, Weiqiong;
Wang, Weiqing

Publication type:

Article

Association of sedentary time and carotid atherosclerotic plaques in patients with type 2 diabetes.

Published in:

Journal of Diabetes, 2022, v. 14, n. 1, p. 64, doi. 10.1111/1753-0407.13242

By:

Ke, Jing;
Li, Kun;
Ke, Tingyu;
Zhong, Xu;
Zheng, Qidong;
Wang, Yufan;
Li, Li;
Dai, Yuancheng;
Dong, Qijuan;
Ji, Bangqun;
Xu, Fengmei;
Shi, Juan;
Peng, Ying;
Zhang, Yifei;
Zhao, Dong;
Wang, Weiqing

Publication type:

Article

Echinatin Inhibits Oxidative Stress and Inflammatory Processes in Trophoblast Cells by Inhibiting TLR4-MyD88-NF-κB Pathway in Preeclampsia.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2024, v. 2024, p. 1, doi. 10.1155/2024/2296727

By:

Deng, Xiangyun;
Chen, Hu;
Zhang, Yang;
Xu, Fengmei;
Zhou, Qian

Publication type:

Article

hnRNPK inhibits GSK3β Ser9 phosphorylation, thereby stabilizing c-FLIP and contributes to TRAIL resistance in H1299 lung adenocarcinoma cells.

Published in:

Scientific Reports, 2016, p. 22999, doi. 10.1038/srep22999

By:

Gao, Xuejuan;
Feng, Junxia;
He, Yujiao;
Xu, Fengmei;
Fan, Xiaoqin;
Huang, Wensi;
Xiong, Haiting;
Liu, Qiuyu;
Liu, Wanting;
Liu, Xiaohui;
Sun, Xuesong;
He, Qing-Yu;
Zhang, Qihao;
Liu, Langxia

Publication type:

Article

Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin and inadequately controlled with metformin monotherapy or drug‐naive: A multicentre, randomized, open‐label, prospective study (ACADEMIC)

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 991, doi. 10.1111/dom.14661

By:

Gao, Bin;
Gao, Weiguo;
Wan, Hailong;
Xu, Fengmei;
Zhou, Rong;
Zhang, Xia;
Ji, Qiuhe

Publication type:

Article

Efficacy and safety of saxagliptin compared with acarbose in Chinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: Results of a Phase IV open-label randomized controlled study (the SMART study).

Published in:

Diabetes, Obesity & Metabolism, 2017, v. 19, n. 11, p. 1513, doi. 10.1111/dom.12942

By:

Du, Jin;
Liang, Li;
Fang, Hui;
Xu, Fengmei;
Li, Wei;
Shen, Liya;
Wang, Xueying;
Xu, Chun;
Bian, Fang;
Mu, Yiming

Publication type:

Article

Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus.

Published in:

Journal of Diabetes Investigation, 2020, v. 11, n. 4, p. 896, doi. 10.1111/jdi.13224

By:

Fang, Hui;
Xu, Fengmei;
Du, Jin;
Liang, Li;
Li, Wei;
Shen, Liya;
Wang, Xueying;
Xu, Chun;
Bian, Fang;
Mu, Yiming

Publication type:

Article

Nomogram for Predicting Hypoglycemia in Type 2 Diabetes Mellitus Patients Treated with Insulin Pump During Enteral Nutrition.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2024, v. 17, p. 2147, doi. 10.2147/DMSO.S436390

By:

Wu, Jufei;
Wu, Jishi;
Zhou, Yan;
Lu, Xiaohua;
Zhao, Wane;
Xu, Fengmei

Publication type:

Article

Unraveling the Mechanisms of MicroRNA in Suppressing Hepatitis B Virus Progression: A Comprehensive Review for Designing Treatment Strategies.

Published in:

Hepatitis Monthly, 2024, v. 24, n. 1, p. 1, doi. 10.5812/hepatmon-144239

By:

Huanhuan Song;
Qinghuai Zhang;
Gang Fang;
Xiaofan Luo;
Di Wu;
Hongyi Li;
Kan Zhou;
Xinyi Zhao;
Fengmei Xu;
Yun Zhang;
An Huang

Publication type:

Article